Young S, Raboud J, Dodd Z, DeBeck K, Milloy MJ, Wilson D, Hayashi K, Bayoumi AM, Fairbairn N Examining the association between fentanyl use and perceived adequacy of methadone dose: a retrospective cohort study Drug Alcohol Depend PubMed

Socías ME, Choi JC, Fairbairn N, Johnson C, Wilson D, DeBeck K, Brar R, Hayashi K Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: an interrupted time series analysis Int J Drug Policy PubMed

Moallef S, DeBeck K, Fairbairn N, Cui Z, Brar R, Wilson D, Johnson C, Milloy MJ, Hayashi K Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy Addict Sci Clin Pract PubMed

McAdam E, Hayashi K, Dong H, Cui Z, Sedgemore K, Dietze P, Phillips P, Wilson D, Milloy MJ, DeBeck K Factors associated with perceived decline in the quality of drugs during the COVID-19 pandemic: evidence from community-recruited cohorts of people who use drugs in Vancouver, Canada Drug Alcohol Depend PubMed

Moshkforoush M, DeBeck K, Brar R, Fairbairn N, Cui Z, Milloy MJ, Buxton J, Oldenburger T, McLellan W, Kendall P, Sedgemore K, Wilson D, Kerr T, Hayashi K Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada Harm Reduct J PubMed